Published in Br J Dermatol on July 01, 1995
Paediatric mastocytosis. Arch Dis Child (2002) 0.95
Long-term effect of interferon alpha treatment in mastocytosis. Br J Dermatol (1996) 0.75
Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1. J Immunol (1982) 2.90
Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). J Immunol (1981) 2.74
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med (1990) 2.62
Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol (2006) 2.49
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol (2010) 2.12
Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol (1983) 2.03
Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum (2000) 1.95
Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol (1999) 1.81
Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol (1998) 1.75
Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension. Br J Dermatol (2008) 1.64
Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy. Br J Dermatol (2013) 1.63
IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol (1989) 1.54
Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J Leukoc Biol (1999) 1.53
Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J Clin Invest (1995) 1.49
[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients]. Hautarzt (2004) 1.42
Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol (1990) 1.42
Psoriasis vulgaris treated successfully with mycophenolate mofetil. Br J Dermatol (1998) 1.40
Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. Arch Dermatol Res (2012) 1.38
Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest (1981) 1.37
Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest (1982) 1.33
Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest (1994) 1.29
Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol (2008) 1.28
Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun (1982) 1.27
In vitro correction of the interleukin 2 defect of autoimmune mice. Eur J Immunol (1983) 1.27
The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol (1988) 1.25
Mycosis fungoides: a dermatological masquerader. Br J Dermatol (2007) 1.24
Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol (1995) 1.24
UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J Invest Dermatol (1994) 1.23
Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol (1995) 1.20
A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. Blood (2001) 1.19
Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med (2001) 1.17
Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol (1991) 1.17
Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin. J Biol Chem (1989) 1.17
Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci U S A (1999) 1.16
Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology (1994) 1.16
UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity. J Immunol (1987) 1.15
Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation. J Immunol (1990) 1.14
In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol (1994) 1.14
Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. J Invest Dermatol (1996) 1.13
Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line. J Invest Dermatol (1983) 1.12
Effect of UV irradiation on epidermal cell cytokine production. J Photochem Photobiol B (1989) 1.12
Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol (1991) 1.10
Granulocyte-activating mediators (GRAM): I. Generation by lipopolysaccharide-stimulated mononuclear cells. J Invest Dermatol (1986) 1.09
Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol (1998) 1.08
Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol (2006) 1.07
Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol (2000) 1.07
[Capillaroscopy. Procedure and nomenclature]. Z Rheumatol (2010) 1.06
Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut (2006) 1.06
Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine. J Invest Dermatol (1986) 1.05
Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression. J Invest Dermatol (1990) 1.05
Diffuse melanosis arising from metastatic melanoma: pathogenetic function of elevated melanocyte peptide growth factors. J Am Acad Dermatol (2001) 1.05
Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol (1996) 1.04
The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes. J Invest Dermatol (1983) 1.03
Irradiation induces increase of adhesion molecules and accumulation of beta2-integrin-expressing cells in humans. Int J Radiat Oncol Biol Phys (1999) 1.03
Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem (1998) 1.02
Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for a regulatory role of IL-6, IL-7, TNF beta, and UVB light. J Invest Dermatol (1992) 1.02
The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest (1993) 1.01
alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol (1996) 1.01
Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves. Br J Dermatol (1997) 1.00
Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J Immunol (1997) 1.00
Epidermal cells synthesize a cytokine with interleukin 3-like properties. J Immunol (1985) 0.99
Down-regulation of interferon gamma-activated STAT1 by UV light. Proc Natl Acad Sci U S A (1997) 0.99
Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression. Ann N Y Acad Sci (1999) 0.97
IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol (1994) 0.96
Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J Immunol (2001) 0.96
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
Binding of recombinant interleukin-1 beta to the third complement component and alpha 2-macroglobulin after activation of serum by immune complexes. Blood (1990) 0.95
Expression and complex assembly of calcium-binding proteins MRP8 and MRP14 during differentiation of murine myelomonocytic cells. J Leukoc Biol (1993) 0.95
Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices. J Leukoc Biol (2004) 0.95
Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J Immunol (1996) 0.94
Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology (2003) 0.94
Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation. J Immunol (1999) 0.93
In experimental leishmaniasis deficiency of CD18 results in parasite dissemination associated with altered macrophage functions and incomplete Th1 cell response. Eur J Immunol (2000) 0.93
Human keratinocytes in vivo and in vitro constitutively express the 72-kD heat shock protein. J Invest Dermatol (1993) 0.93
Binding of IL-1 beta to alpha-macroglobulins and release by thioredoxin. J Immunol (1990) 0.93
[Embolia cutis medicamentosa (Nicolau syndrome) after intra-articular injection]. Hautarzt (1999) 0.92
Molecular basis of the alpha-MSH/IL-1 antagonism. Ann N Y Acad Sci (1999) 0.92
Ultraviolet light suppresses IFN-gamma-induced IL-7 gene expression in murine keratinocytes by interfering with IFN regulatory factors. J Immunol (1997) 0.92
An epidermal cell-derived cytokine triggers the in vivo synthesis of serum amyloid A by hepatocytes. J Immunol (1982) 0.91
p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis. Virchows Arch (1997) 0.91
Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity. J Immunol (1999) 0.91
Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis. J Biol Chem (1999) 0.91
Purification of human interleukin 1 by high-performance liquid chromatography. J Chromatogr (1984) 0.91
Aging and the skin immune system. Arch Dermatol (1997) 0.91
Expression of the calcium-binding proteins MRP8 and MRP14 by early infiltrating cells in experimental contact dermatitis. Int Arch Allergy Immunol (1992) 0.90
Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol (2006) 0.90
Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int (1987) 0.90
Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J Immunol (1997) 0.90
Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp Dermatol (2001) 0.90
Corneal epithelial cell--derived thymocyte-activating factor (CETAF). Invest Ophthalmol Vis Sci (1982) 0.90
Efficacy of cyclosporin A in systemic sclerosis. Clin Exp Rheumatol (1991) 0.90
Interaction of murine dendritic cells with collagen up-regulates allostimulatory capacity, surface expression of heat stable antigen, and release of cytokines. J Leukoc Biol (1996) 0.90
Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-alpha. J Immunol (1992) 0.90
The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci (2000) 0.89
Beneficial effects of the melanocortin analogue Nle4-D-Phe7-α-MSH in acne vulgaris. J Eur Acad Dermatol Venereol (2012) 0.89
E-selectin expression in experimental models of inflammation in mice. J Pathol (1996) 0.89